In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis

References

• Ballell, L., Bates, R. H., Young, R. J., Alvarez-Gomez, D., Alvarez-Ruiz, E., Barroso, V., … Cammack, N. (2013). Fueling open ‐ source drug discovery: 177 small molecule leads against tuberculosis. ChemMedChem, 8(2), 313–321.
   PubMed Web of Science ®Google Scholar
• Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., … Jacobs, W. R. (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science (New York, N.Y.), 263(5144), 227–230.
   PubMed Web of Science ®Google Scholar
• Baragaña, B., Hallyburton, I., Lee, M. C. S., Norcross, N. R., Grimaldi, R., Otto, T. D., … Gilbert, I. H. (2015). A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature, 522(7556), 315.
   PubMed Web of Science ®Google Scholar
• Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R. Jr., & Blanchard, J. S. (1998). Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: Enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. The Journal of Infectious Diseases, 178(3), 769–775.
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., & Weissig, H. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242.
   PubMed Web of Science ®Google Scholar
• Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Research, 31(13), 3352–3355.
   PubMed Web of Science ®Google Scholar
• Bobrik, A., Danishevski, K., Eroshina, K., & McKee, M. (2005). Prison health in Russia: The larger picture. Journal of Public Health Policy, 26(1), 30–59.
   PubMed Web of Science ®Google Scholar
• Bryk, R., Lima, C. D., Erdjument-Bromage, H., Tempst, P., & Nathan, C. (2002). Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science, 295(5557), 1073–1077.
   PubMed Web of Science ®Google Scholar
• Chan, R. C. Y., Hui, M., Chan, E. W. C., Au, T. K., Chin, M. L., Yip, C. K., … Cheng, A. F. B. (2007). Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. Journal of Antimicrobial Chemotherapy, 59(5), 866–873.
   PubMed Web of Science ®Google Scholar
• Czabotar, P. E., Westphal, D., Dewson, G., Ma, S., Hockings, C., Fairlie, W. D., … Colman, P. M. (2013). Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell, 152(3), 519–531.
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2010). The Pymol molecular graphics system, Version 1.2 r3pre. New York, NY: Schrödinger, LLC.
   Google Scholar
• Dookie, N., Rambaran, S., Padayatchi, N., Mahomed, S., & Naidoo, K. (2018). Evolution of drug resistance in Mycobacterium tuberculosis: A review on the molecular determinants of resistance and implications for personalized care. Journal of Antimicrobial Chemotherapy, 73(5), 1138–1151.
   PubMed Web of Science ®Google Scholar
• Dowdy, D. W., Theron, G., Tornheim, J. A., & Kendall, E. A. (2017). Drug-resistant tuberculosis in 2017: At a crossroads. The Lancet Respiratory Medicine, 5(4), 241–242.
   Web of Science ®Google Scholar
• Duan, X., Xiang, X., & Xie, J. (2014). Crucial components of mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors. FEMS Microbiology Letters, 360(2), 87–99.
   PubMed Web of Science ®Google Scholar
• Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y., & Liang, J. (2006). CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Research, 34, W116–W118.
   PubMed Web of Science ®Google Scholar
• Ellis, C. R., Tsai, C. C., Hou, X., & Shen, J. (2016). Constant pH molecular dynamics reveals pH-modulated binding of two small-molecule BACE1 inhibitors. The Journal of Physical Chemistry Letters, 7(6), 944–949. doi:10.1021/acs.jpclett.6b00137.
   PubMed Web of Science ®Google Scholar
• Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., … Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(D1), D1100–D1107.
   PubMed Web of Science ®Google Scholar
• Guardia, A., Gulten, G., Fernandez, R., Gómez, J., Wang, F., Convery, M., … Castro-Pichel, J. (2016). N‐Benzyl‐4‐((heteroaryl) methyl) benzamides: A new class of direct NADH‐dependent 2‐trans enoyl–acyl carrier protein reductase (InhA) inhibitors with antitubercular activity. ChemMedChem, 11(7), 687–701.
   PubMed Web of Science ®Google Scholar
• Harris, R. C., Tsai, C. C., Ellis, C. R., & Shen, J. (2017). Proton-coupled conformational allostery modulates the inhibitor selectivity for β-secretase. The Journal of Physical Chemistry Letters, 8(19), 4832–4837.
   PubMed Web of Science ®Google Scholar
• Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., … Alland, D. (2006). Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 50(8), 2640–2649.
   PubMed Web of Science ®Google Scholar
• Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000). Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 44(4), 1075–1077.
   PubMed Web of Science ®Google Scholar
• Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., … van Embden, J. D. A. (1994). Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study. The Lancet, 344(8918), 293–298.
   PubMed Web of Science ®Google Scholar
• Hillas, P. J., del Alba, F. S., Oyarzabal, J., Wilks, A., & de Montellano, P. R. O. (2000). The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis. Journal of Biological Chemistry, 275(25), 18801–18809.
   PubMed Web of Science ®Google Scholar
• Hitchcock, S. A., & Pennington, L. D. (2006). Structure − brain exposure relationships. Journal of Medicinal Chemistry, 49(26), 7559–7583.
   PubMed Web of Science ®Google Scholar
• Iseman, M. D. (1993). Treatment of multidrug-resistant tuberculosis. The New England Journal of Medicine, 329(11), 784–791.
   PubMed Web of Science ®Google Scholar
• Jadaun, A., Sudhakar, D. R., Subbarao, N., & Dixit, A. (2015). In silico screening for novel inhibitors of DNA polymerase III alpha subunit of Mycobacterium tuberculosis (M.tbDnaE2, H37Rv). PLoS One, 10(3), e0119760.
   PubMed Web of Science ®Google Scholar
• Jena, L., Waghmare, P., Kashikar, S., Kumar, S., & Harinath, B. C. (2014). Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug. International Journal of Mycobacteriology, 3(4), 276–282.
   PubMedGoogle Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748.
   PubMed Web of Science ®Google Scholar
• Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000). Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tubercle and Lung Disease, 80(1), 47–56.
   PubMedGoogle Scholar
• Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews. Drug Discovery, 3(11), 935.
   PubMed Web of Science ®Google Scholar
• Kujawski, J., Popielarska, H., Myka, A., Drabińska, B., & Bernard, M. K. (2012). The log P parameter as a molecular descriptor in the computer-aided drug design – An overview. Computational Methods in Science and Technology, 18(2), 81–88.
   Google Scholar
• Lee, A. S., Lim, I. H., Tang, L. L., Telenti, A., & Wong, S. Y. (1999). Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrobial Agents and Chemotherapy, 43(8), 2087–2089.
   PubMed Web of Science ®Google Scholar
• Lee, H., Cho, S. N., Bang, H. E., Lee, J. H., Bai, G. H., Kim, S. J., & Kim, J. D. (2000). Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. The International Journal of Tuberculosis and Lung Disease, 4(5), 441–447.
   PubMed Web of Science ®Google Scholar
• Leung, E. T. Y., Ho, P. L., Yuen, K. Y., Woo, W. L., Lam, T. H., Kao, R. Y., … Yam, W. C. (2006). Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: Identification of a novel mutation in inhA. Antimicrobial Agents and Chemotherapy, 50(3), 1075–1078.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17.
   Web of Science ®Google Scholar
• Lordi, G. M., & Reichman, L. B. (1991). Treatment of tuberculosis. American Family Physician, 44(1), 219–224.
   PubMed Web of Science ®Google Scholar
• Louw, G. E., Warren, R. M., van Pittius, N. G., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009). A balancing act: Efflux/influx in mycobacterial drug resistance. Antimicrobial Agents and Chemotherapy, 53(8), 3181–3189.
   PubMed Web of Science ®Google Scholar
• Master, S. S., Springer, B., Sander, P., Boettger, E. C., Deretic, V., & Timmins, G. S. (2002). Oxidative stress response genes in Mycobacterium tuberculosis: Role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology, 148(10), 3139–3144.
   PubMed Web of Science ®Google Scholar
• Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003). ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy, 47(12), 3799–3805.
   PubMed Web of Science ®Google Scholar
• Morton, D. J., Whitby, P. W., Jin, H., Ren, Z., & Stull, T. L. (1999). Effect of multiple mutations in the hemoglobin-and hemoglobin-haptoglobin-binding proteins, HgpA, HgpB, and HgpC, of Haemophilus influenzae Type b. Infection and Immunity, 67(6), 2729–2739.
   PubMed Web of Science ®Google Scholar
• Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., Van Soolingen, D., & Van Embden, J. D. (1996). Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and-susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance. The Journal of Infectious Diseases, 173(1), 196–202.
   PubMed Web of Science ®Google Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33.
   PubMed Web of Science ®Google Scholar
• Ohlrogge, J., & Browse, J. (1995). Lipid biosynthesis. The Plant Cell, 7(7), 957.
   PubMed Web of Science ®Google Scholar
• Ramaswamy, S., & Musser, J. M. (1998). Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and Lung Disease, 79(1), 3–29.
   PubMedGoogle Scholar
• Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., … Graviss, E. A. (2003). Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 47(4), 1241–1250.
   PubMed Web of Science ®Google Scholar
• Rebollo-Lopez, M. J., Lelièvre, J., Alvarez-Gomez, D., Castro-Pichel, J., Martínez-Jiménez, F., Papadatos, G., … Barros-Aguire, D. (2015). Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery. PLoS One, 10(12), e0142293. doi:10.1371/journal.pone.0142293.
   PubMed Web of Science ®Google Scholar
• Ristow, M., Möhlig, M., Rifai, M., Schatz, H., Feldmann, K., & Pfeiffer, A. (1995). New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. The Lancet, 346(8973), 502–503.
   PubMed Web of Science ®Google Scholar
• Rozwarski, D. A., Grant, G. A., Barton, D. H., Jacobs, W. R., & Sacchettini, J. C. (1998). Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science (New York, N.Y.), 279(5347), 98–102.
   PubMed Web of Science ®Google Scholar
• Sandgren, A., Strong, M., Muthukrishnan, P., Weiner, B. K., Church, G. M., & Murray, M. B. (2009). Tuberculosis drug resistance mutation database. PLoS Medicine, 6(2), e1000002.
   PubMed Web of Science ®Google Scholar
• Sarkar, A., & Kellogg, G. E. (2010). Hydrophobicity-shake flasks, protein folding and drug discovery. Current Topics in Medicinal Chemistry, 10(1), 67–83.
   PubMed Web of Science ®Google Scholar
• Scheraga, H. A., Némethy, G., & Steinberg, I. Z. (1962). The contribution of hydrophobic bonds to the thermal stability of protein conformations. Journal of Biological Chemistry, 237(8), 2506–2508.
   PubMed Web of Science ®Google Scholar
• Sharma, S. K., & Mohan, A. (2006). Multidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis control. Chest, 130(1), 261–272.
   PubMed Web of Science ®Google Scholar
• Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. M., Telles, M. A., Kritski, A., … Rossetti, M. L. R. (2003). Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. Journal of Clinical Microbiology, 41(9), 4471–4474.
   PubMed Web of Science ®Google Scholar
• Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S. I. (1996). Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiology Letters, 144(1), 103–108.
   PubMed Web of Science ®Google Scholar
• Tousif, S., Ahmad, S., Bhalla, K., Moodley, P., & Das, G. (2015). Challenges of tuberculosis treatment with DOTS: An immune impairment perspective. Journal of Cell Science & Therapy, 6(5), 1.
   Google Scholar
• Walker, T. M., Merker, M., Knoblauch, A. M., Helbling, P., Schoch, O. D., van der Werf, M. J., … Witschi, M. (2018). A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: A molecular epidemiological study. The Lancet Infectious Diseases, 18(4), 431.
   PubMed Web of Science ®Google Scholar
• Whitfield, M. G., Soeters, H. M., Warren, R. M., York, T., Sampson, S. L., Streicher, E. M., … van Rie, A. (2015). A global perspective on pyrazinamide resistance: Systematic review and meta-analysis. PLoS One, 10(7), e0133869.
   PubMed Web of Science ®Google Scholar
• WHO. (2015). Multi-drug-resistant tuberculosis (MDR-TB) – Update. Geneva: WHO.
   Google Scholar
• Wolber, G., & Kosara, R. (2006). Pharmacophores from macromolecular complexes with LigandScout. Pharmacophores and Pharmacophore Searches, 32, 131–150.
   Google Scholar
• Xu, D., & Zhang, Y. (2011). Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophysical Journal, 101(10), 2525–2534.
   PubMed Web of Science ®Google Scholar
• Yang, S. Y. (2010). Pharmacophore modeling and applications in drug discovery: Challenges and recent advances. Drug Discovery Today, 15(11–12), 444–450.
   PubMed Web of Science ®Google Scholar
• Youatt, J. (1969). A review of the action of isoniazid. The American Review of Respiratory Disease, 99(5), 729–749.
   PubMed Web of Science ®Google Scholar
• Zenteno-Cuevas, R., Zenteno, J. C., Cuellar, A., Cuevas, B., Sampieri, C. L., Riviera, J. E., & Parissi, A. (2009). Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico. Memorias Do Instituto Oswaldo Cruz, 104(3), 468–472.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992). The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature, 358(6387), 591.
   PubMed Web of Science ®Google Scholar